rss0393
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Mar 31, 2024 (NCT06308393)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07158151 | Phase 2 | Sep 25, 2025 | Reistone Biopharma Company Limited |
| NCT07102888 | Phase 2 | Aug 31, 2025 | Hengrui Therapeutics, Inc. |
| NCT06918743 | Phase 2 | Apr 30, 2025 | Hengrui Therapeutics, Inc. |
| NCT06308393 | Phase 1 | Mar 31, 2024 | Hengrui Therapeutics, Inc. |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Hengrui Therapeutics, Inc. | For profit | 3 | 3 | 2 | 2024 |
| Reistone Biopharma Company Limited | For profit | 1 | 1 | 1 | 2025 |
2 organizations
Page 1 / 1